Bio-Path Holdings, Inc.
P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION

Last updated:

Abstract:

Provided herein are improved delivery systems for oligonucleotides, said delivery system comprising a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide, which targets a STAT3-encoding polynucleotide. Methods of treating patients with said delivery systems are also provided.

Status:
Application
Type:

Utility

Filling date:

4 Jun 2021

Issue date:

28 Apr 2022